Original Article
Free Access
Regulation of cyclin-dependent kinase inhibitor p21WAF1/Cip1/Sdi1 gene expression in hepatic regeneration
J H Albrecht,
A H Meyer,
M Y Hu,
J H Albrecht
Department of Medicine, Hennepin County Medical Center, Minneapolis, MN 55415, USA
Search for more papers by this authorA H Meyer
Department of Medicine, Hennepin County Medical Center, Minneapolis, MN 55415, USA
Search for more papers by this authorM Y Hu
Department of Medicine, Hennepin County Medical Center, Minneapolis, MN 55415, USA
Search for more papers by this authorJ H Albrecht,
A H Meyer,
M Y Hu,
J H Albrecht
Department of Medicine, Hennepin County Medical Center, Minneapolis, MN 55415, USA
Search for more papers by this authorA H Meyer
Department of Medicine, Hennepin County Medical Center, Minneapolis, MN 55415, USA
Search for more papers by this authorM Y Hu
Department of Medicine, Hennepin County Medical Center, Minneapolis, MN 55415, USA
Search for more papers by this authorAbstract
WAF1/Cip1/Sdi1 (p21) is the prototype of a family of proteins that inhibit cyclin-dependent kinases and regulate cell cycle progression in eukaryotic cells. In addition to normal cell cycle progression, p21 is involved in growth suppression mediated by p53 and transforming growth factor β (TGFβ), differentiation, and apoptosis. To gain insight into the possible involvement of p21 in liver cell growth, the expression and regulation of the p21 gene was evaluated in rodent models of liver regeneration and specimens of human liver diseases. Little p21 mRNA was detected in normal liver tissue. After growth stimulation in vivo by 70% partial hepatectomy (PH), the p21 transcript was upregulated in a biphasic manner, with enhanced expression during G1 phase and following S phase. The induction of p21 after PH was regulated primarily at the post-transcriptional level and was due to enhanced mRNA stability. Inhibition of protein synthesis with cycloheximide rapidly induced p21 expression, primarily by post-transcriptional stabilization of the transcript. Hepatic p21 mRNA was also induced by dietary protein deprivation in normal mice. Expression of the p21 gene after PH was similar in p53-deficient (p53 -/-) and wild-type mice, but was p53-dependent following protein deprivation. Primary hepatocytes in culture demonstrated increased p21 expression after treatment with hepatocyte growth factor, TGFβ, and activin A. p21 mRNA was upregulated in human liver diseases, suggesting a possible role in hepatic growth regulation in pathologic states. The present study demonstrates that p21 is regulated by p53-dependent and -independent pathways in the liver, and is influenced by both mitogenic and growth inhibitory stimuli.
References
- 1 Pines J. Cyclins and cyclin-dependent kinases: a biochemical view. Bio-chem J 1995; 308: 697–711.
- 2 Morgan DO. Principles of CDK regulation. Nature 1995; 374: 131–134.
- 3 Hartwell LH, Kastan MB. Cell cycle control and cancer. Science 1994; 266: 1821–1828.
- 4 Hunter T, Pines J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 1994; 79: 573–582.
- 5 Okamoto A, Hussain SP, Hagiwara K, Spillare EA, Rusin MR, Demetrick DJ, Serrano M, et al. Mutations in the P16INK4/MTS1/CDKN2, p15INK4B/ MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res 1995; 55: 1448–1451.
- 6 Sherr CJ. Gl phase progression: cycling on cue. Cell 1994; 79: 551–555.
- 7 Peter M, Herskowitz I. Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle. Cell 1994; 79: 181–184.
- 8 Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW, et al. p57KIP2, a structurally distinct member of the p21CIPI Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 1995; 9: 650–662.
- 9 Pines J. p21 inhibits cyclin shock. Nature 1994; 369: 520–521.
- 10 el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parson R, Trent JM, Lin D, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817–825.
- 11 el-Deiry WS, Harper JW, O'Conner PM, Velculescu VE, Canman CE, Jack-man J, Pietenpol JA, et al. Wafl/Cip1 is induced in p53-mediated Gl arrest and apoptosis. Cancer Res 1994; 54: 1169–1174.
- 12 Marx J. Cell cycle inhibitors may help brake growth as cells develop. Science 1995; 267: 963–964.
- 13 Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR. Cloning senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994; 211: 90–98.
- 14 Zhang H, Hannon GJ, Beach D. p21-containing cyclin kinases exist in both active and inactive states. Genes Dev 1994; 8: 1750–1758.
- 15 Waga S, Hannon GJ, Beach D, Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 1994; 369: 574–578.
- 16 Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 1994; 54: 3391–3395.
- 17 Li Y, Jenkins CW, Nichols MA, Xiong Y. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene 1994; 9: 2261–2268.
- 18 Sheikh MS, Li XS, Chen JC, Shao ZM, Ordonez JV, Fontana JA. Mechanisms of regulation of WAFl/Cip1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene 1994; 9: 3407–3415.
- 19 Schwaller J, Koeffler HP, Niklaus G, Loetscher P, Nagel S, Fey MF, Tobler A. Posttranscriptional stabilization underlies p53-independent induction of P21WAF1CIP/SDI1 in differentiating human leukemic cells. J Clin Invest 1995; 95: 973–979.
- 20 Akashi M, Hachiya M, Osawa Y, Spirin K, Suzuki G, Koeffler HP. Irradiation induces WAF1 expression through a p53-independent pathway in KG-1 cells. J Biol Chem 1995; 270: 19181–19187.
- 21 Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vo-gelstein B, et al. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 1995; 9: 935–944.
- 22 Nakanishi M, Adami GR, Robertoye RS, Noda A, Venable SF, Dimitrov D, Pereira-Smith OM, et al. Exit from G0 and entry into the cell cycle of cells expressing p21sdil antisense RNA. Proc Natl Acad Sci U S A 1995; 92: 4352–4356.
- 23 Fan Z, Lu Y, Wu X, DeBlasio A, Koff A, Mendelsohn J. Prolonged induction of p21cipl/WAF1/CDK2/PCNA complex by epidermal growth factor receptor activation mediates ligand-induced A431 growth inhibition. J Cell Biol 1995; 131: 235–242.
- 24 Hoffman AL, Rosen HR, Ljubimova JU, Sher L, Podesta LG, Demetriou AA, Makowka L. Hepatic regeneration: current concepts and clinical implications. Semin Liver Dis 1994; 14: 190–210.
- 25 Fausto N, Webber EM. Control of liver growth. Crit Rev Euk Gene Exp 1993; 3: 117–135.
- 26 Lu XP, Koch KS, Lew DJ, Dulic V, Pines J, Reed SI, Hunter T, et al. Induction of cyclin mRNA and cyclin-associated histone H1 kinase during liver regeneration. J Biol Chem 1992; 267: 2841–2844.
- 27 Albrecht JH, Hoffman JS, Kren BT, Steer CJ. Cyclin and cyclin-dependent kinase 1 mRNA expression in models of regenerating liver and human liver diseases. Am J Physiol 1993; 265: G857–G864.
- 28 Loyer P, Glaise D, Cariou S, Baffet G, Meijer L, Guguen-Guillouzo C. Expression and activation of cdks (1 and 2) and cyclins in the cell cycle progression during liver regeneration. J Biol Chem 1994; 269: 2491–2500.
- 29 Trembley JH, Kren BT, Steer CJ. Posttranscriptional regulation of cyclin B messenger RNA expression in the regenerating rat liver. Cell Growth Differ 1994; 5: 99–108.
- 30 Castro A, Jaumot M, Verges M, Agell N, Bachs O. Microsomal localization of cyclin A and CDK2 in proliferating rat liver cells. Biochem Biophys Res Commun 1994; 201: 1072–1077.
- 31 Albrecht JH, Hu MY, Cerra FB. Distinct patterns of cyclin Dl regulation in models of liver regeneration and human liver. Biochem Biophys Res Commun 1995; 209: 648–655.
- 32 Noguchi S, Ohba Y, Oka T. The role of transcription and messenger RNA stability in the regulation of epidermal growth factor receptor gene expression in regenerating mouse liver. Hepatology 1992; 15: 88–96.
- 33 Mead JE, Braun L, Martin DA, Fausto N. Induction of replicative competence (“priming”) in normal liver. Cancer Res 1990; 50: 7023–7030.
- 34 Seglen PO. Preparation of rat liver cells. Exp Cell Res 1972; 74: 450–454.
- 35 Berry MN, Edwards AM, Barritt GJ. Monolayer culture of hepatocytes. In: Isolated Hepatocytes: Preparation, properties, and applications, edited by RH Burdon and PH van Knippenberg. New York: Elsevier, 1991: 285–286.
- 36 Sargent TD, Wu JR, Sala-Trepat JM, Wallace RB, Reyes AA, Bonner J. The rat serum albumin gene: analysis of cloned sequences. Proc Natl Acad Sci U S A 1979; 76: 3256–3260.
- 37 Miller AD, Currant T, Verma IM. c-fos protein can induce cellular transformation: a novel mechanism of activation of a cellular oncogene. Cell 1984; 36: 51–60.
- 38 Donehower LA, Harvey M, Slagle BL, McCarther MJ, Montgomery CA, Butel JS, Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992; 356: 215–221.
- 39 Datto MB, Li Y, Panus JF, Howe DJ, Xiong Y, Wang XF. Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci USA 1995; 92: 5545–5549.
- 40 Friedman JM, Chung EY, Darnell JE. Gene expression during liver regeneration. J Mol Biol 1984; 179: 37–53.
- 41 Alcorn JA, Feitelberg SP, Brenner DA. Transient induction of c-Jun during hepatic regeneration. Hepatology 1990; 11: 909–915.
- 42 Sobczak J, Mechti N, Tournier MF, Blanchard JM, Duguet M. c-myc and c-fos gene regulation during mouse liver regeneration. Oncogene 1989; 4: 1503–1508.
- 43 Morello D, Fitzgerald MJ, Babinet C, Fausto N. c-myc, c-fos, and c-jun Regulation in the regenerating livers of normal and H-2K/c-myc transgenic mice. Mol Cell Biol 1990; 10: 3185–3193.
- 44 Peavy DE, Taylor JM, Jefferson LS. Time course of changes in albumin synthesis and mRNA in diabetic and insulin-treated diabetic rats. Am J Physiol 1985; 248: E656–E663.
- 45 Herschmann HR. Primary response genes induced by growth factors and tumor promoters. Annu Rev Biochem 1991; 60: 281–319.
- 46 Schiavi SC, Belasco JG, Greenberg ME. Regulation of proto-oncogene mRNA stability. Biochim Biophys Acta 1992; 1114: 95–106.
- 47 Kren BT, Trembley JH, Steer CJ. Alterations in mRNA stability during rat liver regeneration. Am J Physiol 1996; 270: G763–777.
- 48 Chen CA, Shyu AB. Selective degradation of early-response-gene mRNAs: functional analysis of sequence features of the AU-rich elements. Mol Cell Biol 1994; 14: 8471–8482.
- 49 Diehl AM. Nutrition, hormones, metabolism, and liver regeneration. Semin Liver Dis 1991; 11: 315–320.
- 50 James SJ, Muskhelishvili L. Rates of apoptosis and proliferation vary with caloric intake and may influence incidence of spontaneous hepatoma in C57BL/6 X C3H F1 mice. Cancer Res 1994; 54: 5508–5510.
- 51 Himeno Y, Engelman RW, Good RA. Influence of calorie restriction on oncogene expression and DNA synthesis during liver regeneration. Proc Natl Acad Sci U S A 1992; 89: 5497–5501.
- 52 Yasuda H, Mine T, Shibata H, Eto Y, Hasegawa Y, Takeuchi T, Asano S, et al. Activin A: an autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes. J Clin Invest 1993; 92: 1491–1496.
- 53 Li CY, Suardet L, Little JB. Potential role of Wafl/Cip1/p21 as a mediator of TGF-beta cytoinhibitory effect. J Biol Chem 1995; 270: 4971–4974.
- 54 el-Deiry WS, Tokino T, Waldman T, Oliner JD, Velculescu VE, Burrell M, Hill DE, et al. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res 1995; 55: 2910–2919.
- 55 Castilla A, Prieto J, Fausto N. Transforming growth factors β and alpha in a chronic liver disease. N Engl J Med 1991; 324: 933–940.
- 56 Wu H, Wade M, Krall L, Grisham J, Xiong Y, Van Dyke T. Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepato-cyte cell-cycle progression, postnatal liver development, and regeneration. Genes Dev 1996; 10: 245–260.
